ODAC Report Card: Six Takeaways From Accelerated Approval Reviews Of Checkpoint Inhibitors

 
• By Sue Sutter
  
Hurdler
PD-1/L1 sponsors successfully hurdled an FDA panel review four out of six times. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers